Science Explorer Interactive view Map
Company · Littleton · United States

Novus Biologicals (United States)

novusbio.comROR OpenAlex
Research works
1
fractional, all time
Citations
131
174.7 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
22%
world 28%

Not ranked overall: Novus Biologicals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Novus Biologicals (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses.

CAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksCancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksImmunotherapy and Immune…0Immunotherapy and Immune Responses: 0 fractional works
OncologyImmunology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 0 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 0 works
  3. 3 Immunotherapy and Immune Responses Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available22.2%not open77.8%

World: 28% of research is openly available.

with international co-authors33.3%domestic only66.7%

World: 19% is written across borders.

How has Novus Biologicals (United States)'s research output changed?

2005201020152020

Other research institutions in Littleton

All research institutions in Littleton

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.